Pituitary Disorders Education & Support
  • About The PDES
  • Contact us
  • Donation
  • Membership
  • Our Sponsors
  • Surveys
  • News
menu
Home > Pituitary Conditions & Treatments > New Treatments

Navigation

  • About The PDES
  • Contact us
  • Donation
  • Membership
  • Our Sponsors
  • Surveys
  • News

New Treatments

Novartis drug Signifor® recommended by FDA advisory committee for approval to treat patients with Cushing’s disease

Modified-release hydrocortisone (Plenadren) launched for adrenal insufficiency

Sandostatin® LAR Depot:A Long History of Control in Acromegaly

Pituitary Conditions & Treatments

  • Central Hypothyroidism – Diagnosis & Treatment
  • New Treatments
  • Pituitary Information
  • Surgery & Radiation

Navigation

  • Terms
  • Clinical Trials
  • Helpful Links
  • Wellness Center
  • Pituitary Conditions & Treatments
  • Patient & Physician Seminars
  • Pituitary Disorders
  • Newsletter
  • Treatment Centers & Resources
  • Hormone deficiency
  • Patient Stories

Copyright © 2023 www.pituitarydisorder.net. All rights reserved.